These results indicate that neither apoptosis induction nor cell cycle differences are determinants of sensitivity to PI3K pathway inhibitors in SCCHN cell lines and suggest that other biological processes are more relevant. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.